FOXO1 and obesity disorder: Furthermore, the administration of synthetic adropin promotes glycogen synthesis, attenuates glucose production, and improves insulin sensitivity by raising IRS1/2-Akt phosphorylation and lowering the FoxO1 transcript in mouse models of diet-induced obesity [33].